September 22, 2026 erratum Open access From molecular correction to functional rescue: delivery, tissue state, and immunobiology as the principal constraints on dystrophin-restoring therapy in Duchenne muscular dystrophy Frontiers in Pharmacology DOI: 10.3389/fphar.2026.1930837 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 0 References 4 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Duchenne muscular dystrophy 2021 Nature Reviews Disease Primers review Biochemistry, Genetics and Molecular Biology Muscle Physiology and Disorders Open access cited by 15 patents 1,314 citations The 10th Oligonucleotide Therapy Approved: Golodirsen for Duchenne Muscular Dystrophy 2020 Nucleic Acid Therapeutics article Biochemistry, Genetics and Molecular Biology Muscle Physiology and Disorders Open access cited by 1 patent 139 citations Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial 2024 The Lancet Neurology article Biochemistry, Genetics and Molecular Biology Muscle Physiology and Disorders Open access cited by 1 patent 136 citations The Future of Exon Skipping for Duchenne Muscular Dystrophy 2023 Human Gene Therapy article Biochemistry, Genetics and Molecular Biology Muscle Physiology and Disorders Open access 36 citations 4 results